MedTrace Logo

IGNITE-TX Phase III: (Identifying Individuals for Genetic Testing & Treatment) Intervention

NCT07318363 · Status: NOT_YET_RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 2100

Last updated 2026-01-06

No results posted yet for this study

Summary

This trial aims to implement and compare an evidence- and theory-based intervention strategy (IGNITE-TX Intervention) to support probands and their ARRs in family communication, informed decision-making, and navigation to CGT with standard of care, free genetic testing/counseling, and intervention with free genetic testing/counseling.

Conditions

  • Communication
  • Informed Decision-making

Interventions

OTHER

IGNITE-TX program

Participants will complete a questionnaire

OTHER

Genetic Counseling and Testing

Participants will complete a questionnaire

Sponsors & Collaborators

  • M.D. Anderson Cancer Center

    lead OTHER

Principal Investigators

  • Jose Alejandro Rauh-Hain, MD, MPH · M.D. Anderson Cancer Center

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-06-01
Primary Completion
2030-04-01
Completion
2032-04-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07318363 on ClinicalTrials.gov